Ambu A/S (OTCMKTS:AMBBY) Issues Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.10 EPS for the quarter, Zacks reports. Ambu A/S had a net margin of 4.30% and a return on equity of 4.11%.

Ambu A/S Price Performance

Shares of Ambu A/S stock remained flat at $19.01 on Friday. 50 shares of the stock traded hands, compared to its average volume of 161. The company has a market capitalization of $4.47 billion and a price-to-earnings ratio of 158.38. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.49 and a quick ratio of 1.47. The company has a fifty day simple moving average of $15.94 and a 200-day simple moving average of $18.09. Ambu A/S has a 12 month low of $13.02 and a 12 month high of $22.65.

Ambu A/S Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, December 23rd. Stockholders of record on Friday, December 6th were issued a dividend of $0.0557 per share. The ex-dividend date of this dividend was Friday, December 6th. Ambu A/S's dividend payout ratio (DPR) is presently 25.00%.

Ambu A/S Company Profile

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.